WIN Consortium shared on X:
“View the WIN Symposium program and register.
New speaker and program highlights announced for WIN Symposium 2026.
WIN Symposium 2026 is endorsed by ASCO, supporting the scientific positioning of this year’s program.
Taking place October 2-3, 2026 in Providence, Rhode Island, USA, WIN Symposium 2026 will bring together an international faculty of leaders across oncology, precision medicine, translational science, AI and data science, radiation oncology, rare cancers, global collaboration, and clinical implementation.
This year’s program will explore:
Precision Oncology: Innovation and Equity Across the Globe
New speaker highlights include:
Dr. Vivek Subbiah – Keynote speaker, with a focus on precision oncology in practice, including early detection, rare and complex cancers, and tumor-agnostic approaches.
Dr. Charles Balch – Global precision oncology, access, equity, and international collaboration.
Dr. Yves Lussier – Artificial intelligence and data science in precision oncology.
Dr. Benedito A. Carneiro – Translational oncology.
Dr. David Spetzler – AI, genomic profiling, and the changing frontier of precision medicine.
Dr. Stephen Chun – Radiation oncology and checkpoint immunotherapy.
Dr. Jacob Scott – Personalized medicine in radiation oncology.
Dr. Eytan Ruppin – Fast and accessible precision oncology.
Dr. Bicky Thapa – Rare genitourinary cancers in the precision era.
Join the international precision oncology community in Providence for two days of scientific exchange, collaboration, and discussion.
ASCO and American Society of Clinical Oncology are registered trademarks of the American Society of Clinical Oncology, Inc. Used with permission. This is not an ASCO sponsored event.“
